Group 1 - The core point of the announcement is that Zhejiang Lino Fluid Control Technology Co., Ltd. has approved the expected daily related transactions for the year 2026, amounting to no more than RMB 30 million with related parties [3][9][15] - The board meeting was held on January 16, 2026, with all seven directors present, and the meeting procedures complied with relevant regulations [2][4] - The expected daily related transactions include dealings with Jiangsu Fengci New Materials Technology Co., Ltd., Linyi Fengci New Materials Technology Co., Ltd., and Xuzhou Helishi Valve Technology Co., Ltd. [3][9] Group 2 - The expected total amount for daily related transactions in 2026 is set at RMB 30 million, which is the same as the 2025 estimate, while the actual amount for 2025 was RMB 2.3759 million [9][10] - The independent directors and the audit committee have reviewed and approved the proposal for the expected daily related transactions [5][15] - The transactions are considered normal business operations and are expected to be conducted at fair market prices, ensuring compliance and fairness [14][15]

证券代码：600331 证券简称：宏达股份 公告编号：2026-007 四川宏达股份有限公司 2026年第一次临时股东会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 本次会议是否有否决议案：无 一、会议召开和出席情况 (一)股东会召开的时间：2026年1月16日 (二)股东会召开的地点：四川省什邡市宏达金桥大酒店二楼会议室 (三)出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： ■ 表决情况： ■ (四)表决方式是否符合《公司法》及《公司章程》的规定，会议主持情况等。 会议由公司董事会召集，董事长乔胜俊主持，采取现场与网络投票方式，对需审议议案进行了记名投票 表决，会议的召集和表决方式符合《公司法》《公司章程》及国家相关法律、法规的规定。 (五)公司董事和董事会秘书的列席情况 1、公司在任董事9人，列席6人，非独立董事王浩、张建，独立董事郑亚光因工作原因未能列席本次股 东会； 2、董事会秘书王延俊因身体原因未能列席本次股东会；公司高级管理人员刘应刚因工作原因未能列席 本次股东会。 ...

Group 1 - The company announced the repurchase and cancellation of 30,000 restricted stocks due to the death of one of the incentive plan participants, resulting in a reduction of the total share capital by 30,000 yuan [1][2] - The company held its first extraordinary shareholders' meeting of 2026 on January 16, 2026, where the proposal for the repurchase of restricted stocks was approved [7][16] - The shareholders' meeting had a total of 492 participants, representing 257,913,778 shares, which is 34.0340% of the total voting shares [14] Group 2 - The company notified creditors that they have 45 days from the announcement date to claim debts or request guarantees due to the capital reduction [2][5] - The meeting's voting process combined both on-site and online methods, ensuring compliance with legal regulations [12][20] - Legal opinions confirmed that the meeting's procedures and voting results were legitimate and compliant with relevant laws [20]

证券代码：688168 证券简称：安博通 公告编号：2026-001 北京安博通科技股份有限公司关于补充确认2025年度日常关联交易的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ● 本日常关联交易确认事项无需提交股东会审议。 （二）本次日常关联交易确认金额和类别 1. 补充确认2025年度日常关联交易情况如下： ■ 二、关联人基本情况和关联关系 ● 日常关联交易对上市公司的影响：本次补充确认的关联交易属于公司日常关联交易，是正常生产经营 业务，不存在损害公司及股东利益的情况，不会对关联人形成较大的依赖。 一、日常关联交易基本情况 （一）日常关联交易履行的审议程序 北京安博通科技股份有限公司（以下简称"公司"）于2026年1月16日召开第三届董事会第二十三次会 议，审议通过了《关于补充确认 2025 年度日常关联交易的议案》，关联董事钟竹回避表决，出席会议 的非关联董事一致同意通过该议案。 2026年1月16日，公司独立董事召开第三届独立董事专门会议第三次会议，审议通过了《关于补充确认 2025年度 ...

Group 1 - The company announced its 2026 annual routine related party transactions, which require shareholder meeting approval and are essential for normal operations [2][3] - The routine related party transactions for 2026 are expected to amount to 1,127 million yuan, covering procurement, sales, and services [6] - The company has a history of related party transactions with Jilin Bank, including loans and deposits, with a loan balance of 7,666.65 million yuan and interest expenses of 39.98 million yuan for 2025 [4][5] Group 2 - The company’s board of directors approved the routine related party transactions during a meeting on January 16, 2026, with unanimous consent from all independent directors [3][49] - The company will continue to engage in financing and guarantee activities with Jilin Bank, although specific amounts for 2026 are not yet available [7] - The company emphasizes that all related party transactions are conducted at fair prices and conditions, ensuring no harm to the interests of the company and its shareholders [19][17] Group 3 - The company has provided guarantees for its subsidiaries, including a guarantee of 32.348 million yuan for Jilin D Pharmaceutical Co., Ltd. and 3.7 million yuan for Jilin Yatai Dinglu Cement Co., Ltd. [25][28] - The total amount of guarantees provided by the company and its subsidiaries will reach 15,152.80 million yuan, which is 544.92% of the company's net assets as of December 31, 2024 [31] - The company plans to hold its first temporary shareholder meeting on February 3, 2026, to discuss various proposals, including the routine related party transactions and guarantees [34][36]

证券日报网讯1月15日，神马股份（600810）发布公告称，公司第十二届董事会第七次会议审议通过 《关于发行短期融资券的议案》《关于公司2025年日常关联交易执行情况及2026年日常关联交易预计情 况的议案》。 ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 本次会议是否有否决议案：无 一、会议召开和出席情况 ■ (四)表决方式是否符合《公司法》及《公司章程》的规定，会议主持情况等。 (一)股东会召开的时间：2026年1月15日 (二)股东会召开的地点：安徽省滁州市定远县炉桥镇安徽华塑股份有限公司会议室 (三)出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： 本次会议由公司董事会召集，公司董事长路明先生主持本次会议。本次会议采取现场和网络投票相结合 的方式召开，现场会议采取记名投票表决的方式，本次会议的召集、召开及表决方式均符合《公司法》 及《公司章程》的有关规定。 (五)公司董事和董事会秘书的列席情况 1、公司在任董事9人，列席9人，其中董事蒋园园先生、范海滨先生、朱继平先生、黄伟新先生以视频 方式列席本次会议； 2、公司董事会秘书毕刚先生列席会议；公司部分高级管理人员列席会议。 二、议案审议情况 1、议案名称：关于2026年度日常关联交易预计的议案 审议结果：通过 表决情况： ■ (二)涉及重大事 ...

Group 1 - The core point of the announcement is that Sichuan Huiyuan Optical Communication Co., Ltd. has held its 13th Board of Directors' fifth meeting, where it approved the expected daily related transactions for 2026, amounting to no more than 90.15 million yuan [3][10][20]. - The meeting was conducted on January 15, 2026, with all six board members present, and it complied with relevant laws and regulations [2][4]. - The expected daily related transactions involve the subsidiary Hefei Yuanfeng Optoelectronics Co., Ltd. selling products and services to the related party Wuhu Anrui Optoelectronics Co., Ltd. [3][10]. Group 2 - The board's resolution regarding the related transactions will be submitted to the shareholders' meeting for approval [5][6]. - The first temporary shareholders' meeting of 2026 is scheduled for February 2, 2026, at 14:50, to discuss the approved matters [6][25]. - The company ensures that the transaction prices are based on market prices and adhere to principles of fairness and transparency [17][21]. Group 3 - The related party, Wuhu Anrui Optoelectronics Co., Ltd., is associated with the company through its major shareholder, Fujian Sanan Group Co., Ltd., which holds 5% of the company's shares [15][20]. - The expected total amount for the daily related transactions is capped at 90.15 million yuan for the year 2026 [10][20]. - The independent directors have reviewed and approved the related transactions, confirming compliance with legal and regulatory requirements [21][22].

Group 1 - The core point of the announcement is the approval of the expected daily related transactions for 2026, which includes leasing factory space and selling products to related parties, aimed at ensuring operational stability and enhancing business efficiency [3][11][16] - The board meeting was held on January 15, 2026, with all five directors present, and the meeting complied with relevant laws and regulations [2][4] - The expected daily related transactions are based on the actual needs of the company's operations and are conducted at fair market prices, ensuring no harm to the interests of all shareholders, especially minority shareholders [9][10][16] Group 2 - The expected daily related transactions for 2026 include leasing factory space and selling products, which are essential for maintaining operational continuity and expanding sales channels [3][11][16] - The company has already signed a lease agreement with a related party for approximately 6,765.30 square meters of factory space, with the lease term from August 1, 2025, to July 31, 2030 [15] - The independent directors have reviewed and approved the expected transactions, confirming that they do not affect the company's independence or create significant reliance on related parties [10][12][16]

Core Viewpoint - The announcement details the expected daily related transactions for 2026 by Pulaike Biological Engineering Co., Ltd., emphasizing that these transactions are necessary for the company's operations and will not harm the interests of shareholders, particularly minority shareholders [2][3]. Group 1: Daily Related Transactions Overview - The estimated amount for daily related transactions in 2026 is 39.24 million yuan, accounting for 1.49% of the audited net assets for 2024, and does not require shareholder meeting approval [3]. - The board of directors, including independent directors, has reviewed and approved the proposal, confirming that the transactions are fair and reasonable, and will not affect the company's independence or ongoing operations [3][14]. Group 2: Related Parties and Relationships - The related parties include several pet hospitals and clinics, all controlled by a parent company, with the actual controller of Pulaike also controlling these entities, establishing a clear related party relationship [7][11]. - Other related parties include Zhongke Gene and its subsidiaries, which are also under the same actual control as Pulaike, further solidifying the interconnectedness of these entities [9][11]. Group 3: Transaction Details and Pricing Policies - The main content of the daily transactions includes the sale of goods, provision of leasing services, purchase of goods, and acceptance of labor services, with pricing based on market rates or cost-plus methods to ensure fairness [13]. - The transactions are designed to meet the company's operational needs and are executed in accordance with relevant contracts, ensuring that they do not harm the company's interests or financial status [14].